Paper · 350592

Sequential use of hapten-gelatin fractionation and fluorescence-activated cell sorting in the enrichment of hapten-specific B llymphocytes.

Nossal GJ and 2 others. Eur J Immunol, 1978. Cited by 54 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Sequential use of hapten-gelatin fractionation and fluorescence-activated cell sorting in the enrichment of hapten-specific B llymphocytes. Papers, record 350592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/350592

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Sequential use of hapten-gelatin fractionation and fluorescence-activated cell sorting in the enrichment of hapten-specific B llymphocytes.; PubMed
Journal: Eur J Immunol; PubMed
Year: 1978; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/350592/; PubMed
DOI: https://doi.org/10.1002/eji.1830080302; PubMed
The journal: https://conductscience.org/library/journal-index/1273201; PubMed
Citations, by iCite: 54; iCite
Relative citation ratio, by iCite: 0.95; iCite
Revised in PubMed: 2006-11-15; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Nossal GJ	G J
2	Pike BL	B L
3	Battye FL	F L

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Antibody Specificity	Major topic
B-Lymphocytes	Major topic
Cell Separation	Major topic
Animals
Antibody Formation
Fluorescent Antibody Technique
Germ-Free Life
Mice
Mice, Inbred Strains
Spleen

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMID	Title	Journal	Year	In Papers	Source
8,145,047	Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells.	J Exp Med	1994	https://conductscience.org/library/papers/8145047	PubMed
6,983,069	Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor.	Proc Natl Acad Sci U S A	1982	https://conductscience.org/library/papers/6983069	PubMed
6,968,812	Relative sensitivity of fetal and newborn mice to induction of hapten-specific B cell tolerance.	J Exp Med	1980	https://conductscience.org/library/papers/6968812	PubMed
6,966,401	Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen.	Proc Natl Acad Sci U S A	1980	https://conductscience.org/library/papers/6966401	PubMed
6,334,854	Human interleukin 2 can promote the growth and differentiation of single hapten-specific B cells in the presence of specific antigen.	Proc Natl Acad Sci U S A	1984	https://conductscience.org/library/papers/6334854	PubMed
6,309,444	Enrichment and depletion of thyroglobulin autoantibody synthesizing lymphocytes.	Clin Exp Immunol	1983	https://conductscience.org/library/papers/6309444	PubMed
6,232,611	Single-cell studies on hapten-specific B cells: response to T-cell-dependent antigens.	Proc Natl Acad Sci U S A	1984	https://conductscience.org/library/papers/6232611	PubMed
6,174,979	Antibody production by single, hapten-specific B lymphocytes: an antigen-driven cloning system free of filler or accessory cells.	Proc Natl Acad Sci U S A	1981	https://conductscience.org/library/papers/6174979	PubMed
3,889,907	A high-efficiency cloning system for single hapten-specific B lymphocytes that is suitable for assay of putative growth and differentiation factors.	Proc Natl Acad Sci U S A	1985	https://conductscience.org/library/papers/3889907	PubMed
3,877,937	Interleukin 1 can act as a B-cell growth and differentiation factor.	Proc Natl Acad Sci U S A	1985	https://conductscience.org/library/papers/3877937	PubMed

1 to 10 of 13

See all 13 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/350592

GET https://conductscience.org/api/papers/v1/350592/authors

API reference For AI assistants